|
|
Alzheimer’s Weekly names ANAVEX 2-73 the number one most promising trial drug in Alzheimer's disease and Anavex’s Phase I clinical program as "Trial
Sources News Release
http://www.sources.com/Releases/NR1118.htm
Publisher: Dr. Cameron Durrant, MD, MBA, Alzheimer's Disease and Pharmaceuticals/Biot
Date Written: 11/01/2011
Year Published: 2011
Resource Type: Article
ANAVEX 2-73 has been named 2010’s “most promising trial drug” by the editorial staff at Alzheimer’s Weekly.
Abstract: Hoboken, NJ – January 6, 2011 - Anavex Life Sciences Corp. (“Anavex”, AVXL.OB) announced today that ANAVEX 2-73 has been named 2010’s “most promising trial drug” by the editorial staff at Alzheimer’s Weekly. The publication selected the ANAVEX 2-73 trial from a field of over 100 trials that treat dementias such as Alzheimer’s and following the review of more than 10,000 articles. Staffers and clinical experts of Alzheimer’s Weekly said that Anavex stands out when scrutinized against their key cr...
To read the full release go to http://www.sources.com/Releases/NR1118.htm
Topics
|
AlterLinks
c/o Sources
© 2025.
|
|
|
|
